| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T579 |
364-591 |
disease:C0376358 |
denotes |
psy. Since 1995 age-referenced PSA levels of 1.25-3.25 ng/ml have been used in combination with a percentage free PSA cutoff of 18%. This PSA cutoff reduction led to a statistically significant migration to lower pathological s |
| T578 |
723-726 |
gene:354 |
denotes |
PSA |
| R1 |
T578 |
T579 |
associated_with |
PSA,psy. Since 1995 age-referenced PSA levels of 1.25-3.25 ng/ml have been used in combination with a percentage free PSA cutoff of 18%. This PSA cutoff reduction led to a statistically significant migration to lower pathological s |
| R2 |
T578 |
T579 |
associated_with |
PSA,psy. Since 1995 age-referenced PSA levels of 1.25-3.25 ng/ml have been used in combination with a percentage free PSA cutoff of 18%. This PSA cutoff reduction led to a statistically significant migration to lower pathological s |
| R3 |
T578 |
T579 |
associated_with |
PSA,psy. Since 1995 age-referenced PSA levels of 1.25-3.25 ng/ml have been used in combination with a percentage free PSA cutoff of 18%. This PSA cutoff reduction led to a statistically significant migration to lower pathological s |
| R4 |
T578 |
T579 |
associated_with |
PSA,psy. Since 1995 age-referenced PSA levels of 1.25-3.25 ng/ml have been used in combination with a percentage free PSA cutoff of 18%. This PSA cutoff reduction led to a statistically significant migration to lower pathological s |
| R5 |
T578 |
T579 |
associated_with |
PSA,psy. Since 1995 age-referenced PSA levels of 1.25-3.25 ng/ml have been used in combination with a percentage free PSA cutoff of 18%. This PSA cutoff reduction led to a statistically significant migration to lower pathological s |
